1-168226097-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_199344.3(SFT2D2):c.18G>C(p.Lys6Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000369 in 1,534,824 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_199344.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFT2D2 | ENST00000271375.7 | c.18G>C | p.Lys6Asn | missense_variant | Exon 1 of 8 | 1 | NM_199344.3 | ENSP00000271375.3 | ||
SFT2D2 | ENST00000367829.5 | c.18G>C | p.Lys6Asn | missense_variant | Exon 1 of 6 | 5 | ENSP00000356803.1 | |||
SFT2D2 | ENST00000630869.1 | c.18G>C | p.Lys6Asn | missense_variant | Exon 1 of 7 | 4 | ENSP00000486492.1 | |||
SFT2D2 | ENST00000471981.1 | n.160G>C | non_coding_transcript_exon_variant | Exon 1 of 7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000532 AC: 81AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000454 AC: 64AN: 141008Hom.: 0 AF XY: 0.000470 AC XY: 35AN XY: 74502
GnomAD4 exome AF: 0.000351 AC: 485AN: 1382546Hom.: 1 Cov.: 30 AF XY: 0.000412 AC XY: 281AN XY: 681648
GnomAD4 genome AF: 0.000532 AC: 81AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.000604 AC XY: 45AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.18G>C (p.K6N) alteration is located in exon 1 (coding exon 1) of the SFT2D2 gene. This alteration results from a G to C substitution at nucleotide position 18, causing the lysine (K) at amino acid position 6 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at